Published Oct 16, 2026 | 9:02 AM ⚊ Updated Oct 16, 2026 | 9:02 AM
One of the most significant claims surrounding collagen supplements is that they can restore the cartilage damaged by osteoarthritis.
Synopsis: Collagen supplements are increasingly promoted for osteoarthritis pain, but can they do more than ease symptoms? Experts explain what clinical evidence reveals about collagen’s potential to reduce pain and improve mobility, why claims of cartilage regeneration remain unproven, and how these supplements fit alongside established approaches to joint pain management.
Collagen supplements are increasingly being marketed as a way to manage joint pain, particularly in people with knee osteoarthritis. Promoted for their potential to support cartilage and improve mobility, these products have attracted interest among people looking for alternatives to painkillers and invasive treatments.
But while some clinical studies suggest that oral collagen may help reduce pain and improve physical function, evidence that it can rebuild damaged cartilage or stop osteoarthritis from progressing remains limited.
Dr Deepak G Shivarathre, director of orthopaedics and joint replacement surgery at Fortis Hospital, Yeshwanthpur, Bengaluru, told South First that collagen supplements should not be considered a proven cure for osteoarthritis.
“Oral collagen has been linked to improvements in pain and physical function in some clinical trials. However, the evidence is patchy between different formulations and collagen should not be considered a tried and tested cure for osteoarthritis,” he said.
Osteoarthritis is a degenerative joint disease in which changes occur in the cartilage, bones and other tissues of a joint. As the condition progresses, people may experience pain, stiffness and difficulty performing everyday activities such as walking, climbing stairs or getting up from a chair.
Collagen is a structural protein found in cartilage, tendons, ligaments and other connective tissues. The reasoning behind supplementation is that consuming collagen could provide components that help support these tissues or influence processes involved in joint health. However, the biological rationale does not, by itself, establish that supplements can repair a damaged joint.
Also Read: Isolation wards in Keralam unfit for patient care, expert probe ordered: Minister
A 2024 meta-analysis published in the journal Osteoarthritis and Cartilage, which included 35 randomised controlled trials involving 3,165 participants, found small-to-moderate improvements in pain and physical function among people receiving collagen derivatives compared with control treatments.
Dr Muhammed Nazeer, senior consultant and group coordinator in the Department of Orthopedics at KIMSHEALTH, Thiruvananthapuram, told South First that the findings offered a reason to investigate collagen further, but should not be interpreted as evidence that every supplement works.
“The evidence suggests that collagen supplements can improve both pain and reported physical function, although the size of the benefit and the certainty of the evidence vary,” he said.
The studies included in the review differed in the collagen formulations used, their doses, treatment durations and the outcomes measured. These differences make it difficult to generalise the results to every collagen product available commercially.
Dr Nazeer also pointed to a separate 2023 meta-analysis of four collagen-peptide trials that reported a statistically significant improvement in pain but judged all four trials to have a high risk of bias.
“A statistically significant difference does not necessarily mean that every patient experiences a noticeable or worthwhile improvement,” he said.
For patients, this distinction matters. A reduction in pain or an improvement in walking ability can make a meaningful difference to daily life. However, the extent of benefit can vary, and the findings do not establish that collagen reverses the underlying joint damage.
Also Read: Rs 2,000–Rs 3,000 a month for years: The prohibitive cost of long-term mental healthcare
One of the most significant claims surrounding collagen supplements is that they can restore the cartilage damaged by osteoarthritis. The available evidence does not establish that outcome.
When collagen is consumed orally, it is broken down during digestion into smaller peptides and amino acids. Some collagen-derived peptides can enter the bloodstream, and researchers are investigating whether they influence cartilage metabolism or inflammatory pathways.
However, the process is more complicated than collagen travelling from the stomach to the knee and becoming new cartilage.
“To think the collagen we eat goes straight to the knee and fixes damaged cartilage is a gross oversimplification,” Dr Shivarathre said.
He explained that some absorbed peptides may influence joint tissues, but this does not mean that an ingested supplement becomes new cartilage.
Dr Nazeer made a similar distinction between improvements in symptoms and changes in the structure of the joint.
“There is a difference between symptomatic improvement, biological effects and structural regeneration,” he said, explaining that the first has some supporting clinical evidence, while the second remains under investigation. Convincing evidence of structural regeneration in clinical practice is lacking.
Osteoarthritis also affects more than cartilage alone. It can involve the underlying bone, the joint lining and surrounding tissues. Consequently, even if a supplement helps reduce symptoms, that does not establish that it has reversed the disease.
“At present, collagen supplements are best viewed as a potential tool for symptom management, not as a proven therapy for reversing structural joint damage,” Dr Shivarathre said.
Also Read: Mass protests and mental health: You care about the cause, but the stress is taking over
Another complication is that collagen is not a single, interchangeable ingredient. Hydrolysed collagen peptides and undenatured type II collagen are different preparations, with different doses and proposed mechanisms of action.
Hydrolysed collagen is broken down into smaller peptides during processing. Undenatured type II collagen retains aspects of its native structure and is proposed to work through a different mechanism involving immune regulation.
Dr Nazeer noted that hydrolysed collagen trials for knee osteoarthritis have commonly used doses measured in grams, including 5–10 g daily, while undenatured type II collagen has been studied at doses measured in milligrams.
“The distinction between milligrams and grams matters. UC-II at 40 mg and hydrolysed collagen at 10 g are different formulations with different proposed mechanisms; their doses cannot be compared directly,” he said.
Therefore, evidence supporting one formulation cannot automatically be used to validate claims about another. Consumers should also be cautious about products claiming to regenerate cartilage, reverse arthritis or guarantee pain relief.
Also Read: The unseen burden of caring for a loved one with mental illness
Both experts said collagen should not displace established approaches to managing osteoarthritis.
Exercise and physiotherapy help strengthen the muscles around the knee, improve mobility and support joint function. Weight management can also reduce stress on the knee in people who are overweight. Medication and other interventions may be considered depending on the severity of symptoms and individual needs.
Dr Shivarathre said collagen could be considered an optional supplement for some people, provided they understood that any benefit might be modest and was not guaranteed.
“If you decide to try collagen, choose a clearly labelled product, set realistic expectations and assess whether it produces a meaningful improvement in your daily activities,” he said.
Dr Nazeer similarly advised against treating collagen as a substitute for appropriate medical care.
“However, if you have symptomatic knee osteoarthritis, can comfortably afford a reputable collagen supplement, understand the limitations of the evidence and wish to try it, a time-limited trial is a reasonable personal choice,” he said.
He added that patients should not expect rapid results or cartilage regeneration, and should not stop prescribed treatment or postpone an appropriate orthopaedic assessment because of a supplement.
(Edited by Dese Gowda)
